Thyagarajan A, Sahu R P
Department of Pharmacology and Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, OH, USA.
World J Pharm Pharm Sci. 2017 Nov;6(11).
There have been intense debates on the use of antioxidants as neoadjuvant therapy or in combination with anti-cancer agents in the treatment of human malignancies. While the safety and effectiveness of commonly used dietary antioxidants have been thoroughly assessed during chemotherapy and radiation therapy in cancer patients, more detailed analysis of their effects are needed to define its potential use in cancer survivors. Here, we summarize the findings of few comprehensive studies that investigated the potential implications of antioxidants in cancer survivors.
关于使用抗氧化剂作为新辅助治疗或与抗癌药物联合用于治疗人类恶性肿瘤，一直存在激烈的争论。虽然在癌症患者的化疗和放疗期间已经对常用膳食抗氧化剂的安全性和有效性进行了全面评估，但仍需要对其效果进行更详细的分析，以确定其在癌症幸存者中的潜在用途。在此，我们总结了一些综合研究的结果，这些研究调查了抗氧化剂对癌症幸存者的潜在影响。
